TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 46.150 million compared to TWD 3.321 million a year ago. Operating loss was TWD 33.682 million compared to TWD 52.845 million a year ago. Net loss was TWD 43.654 million compared to TWD 72.177 million a year ago. Basic loss per share was TWD 0.06 compared to TWD 0.1 a year ago.